Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 80 times.

Year	Filings
2020	2

Investor mix

5 investors on record; lead investors include Versant Ventures, Celgene; 1 has since exited.

Investor type	Count	Share
Venture capital	4	80%
Other / undisclosed	1	20%